Marit Eika Jørgensen

​Professor, chief physician, researcher
Clinical Epidemiology Research

Contact

E-mail: Marit.eika.joergensen@regionh.dk
Phone:  +45 30 91 33 05



 

Research area

Population Surveys in Denmark and Greenland with focus on mapping and prevention of diabetes with focus on:

  • physical activity
  • overweight, fat distribution and obesity
  • prediabetes and undiagnosed diabetes
  • genetics, including gene-lifestyle interactions
  • biomarkers
  • methods for early detection of diabetes

Register studies of patients with diabetes focusing on:

  • Methods to identify people with diabetes in Denmark (development of a national diabetes register)
  • Prediction of future diabetes in Denmark
  • Time trends in mortality in type 1 and type 2 diabetes
  • Time trends in diabetes complications
  • Pharmaco-epidemiological studies
  • Quality of diabetes care
  • Diabetes in vulnerable groups

Current research

Population surveys in Greenland

Aim: To study diabetes and cardiovascular disease in Greenland in repeated population surveys of more than 5000 adult Greenlanders.
Collaborators: Southern Denmark University, Greenland Center for Health Research, Nuuk, Greenland & Copenhagen University

Addition-Pro

Aim: To study risk factors for development of type 2 diabetes and cardiovascular disease among 2082 individuals at high risk of developing diabetes, identified in a screening program in the general population
Collaborators: Section of General Practice,  University of Aarhus

Addition-DK

Aim: The Danish arm of the European Addition-trial to compare effects on cardiovascular disease of intensive treatment with standard care for diabetes diagnosed by a screening program in general practice.
Collaborators: Section of General Practice,  University of Aarhus

Rhapsody

Collaborators: The Rhapsody consortium

Pre-D

Aim: The Pre-D trial compares the short-term (3 months) effectiveness of three glucose-lowering interventions (physical activity, metformin, and dapagliflozin) on glucose variability, body composition, and cardiometabolic risk factors in overweight or obese individuals with pre-diabetes.

Prognosis for patients with diabetes at Steno Diabetes Center Copenhagen

Aim: To study time trends in late diabetic complications and mortality in type 1 and type 2 diabetes based on anonymised data from the electronic patient record since 2001.

DAFFODIL / CVD-real

Aim: Daffodil and CVD-real are retrospective nationwide cohort studies to investigate the treatment of patients with type 2 diabetes from 1995-2014 in Denmark with a specific focus on associations between treatment with SGLT2 inhibitors and heart failure, ischaemic heart disease, stroke and mortality.
Collaborators: Research groups from Sweden, Norway, Finland, UK, Germany and the US. The study is sponsored by Astra Zeneca.

Demography of diabetes in Denmark

Aim: To establish a national diabetes register using available disease and treatment registers in Denmark. The Diabetes Register is used to monitor diabetes prevalence, incidence, complications and life years lost, and to predict future diabetes in Denmark.



Responsible editor